Status:
COMPLETED
Detection of Pulmonary Embolism With Low-dose CT Pulmonary Angiography
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Collaborating Sponsors:
Stanley Thomas Johnson Foundation, Bern, Switzerland
Conditions:
Embolism, Pulmonary
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Computed tomography pulmonary angiography (CTPA) is the imaging method of choice to rule out acute pulmonary embolism based on its high sensitivity and specificity. Unfortunately, CTPA uses iodinated ...
Detailed Description
Background Pulmonary embolism (PE) is the third most common cause of death in the U.S., with at least 650,000 cases occurring annually. Its frequency is similar in Europe. With the new generation of ...
Eligibility Criteria
Inclusion
- CTPA (CT pulmonary angiography) indicated based on clinical suspicion for pulmonary embolism
- patient's body weight \< 100 kg
- informed consent form signed by patient
Exclusion
- contraindication to iodinated contrast media
- pregnancy (if alternative imaging methods to exclude pulmonary embolism are available)
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
504 Patients enrolled
Trial Details
Trial ID
NCT01258140
Start Date
September 1 2008
End Date
December 1 2012
Last Update
January 23 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Diagnostic, Interventional and Pediatric Radiology, University Hospital Bern
Bern, Canton of Bern, Switzerland, 3010